Back

Qualitatively distinct modes of Sputnik V vaccine-neutralization escape by SARS-CoV-2 Spike variants

2021-04-02 infectious diseases Title + abstract only
View on medRxiv
Show abstract

The novel pandemic betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected at least 120 million people since its identification as the cause of a December 2019 viral pneumonia outbreak in Wuhan, China. Despite the unprecedented pace of vaccine development, with six vaccines already in use worldwide, the emergence of SARS-CoV-2 variants of concern (VOC) across diverse geographic locales suggests herd immunity may fail to eliminate the virus. All three official...

Predicted journal destinations

1
Nature Communications
483 training papers
Top 0.3% 28.2%
2
mBio
34 training papers
#1 5.9%
3
The Journal of Infectious Diseases
137 training papers
Top 1% 5.5%
4
Cell
28 training papers
#1 5.0%
5
Clinical Infectious Diseases
219 training papers
Top 7% 5.0%
6
Nature
58 training papers
Top 0.2% 3.8%
7
Nature Medicine
88 training papers
Top 0.7% 3.8%
8
Frontiers in Immunology
140 training papers
Top 6% 1.9%
9
New England Journal of Medicine
49 training papers
Top 1% 1.9%
10
Scientific Reports
701 training papers
Top 81% 1.9%
11
Cell Reports Medicine
49 training papers
Top 2% 1.9%
12
Viruses
79 training papers
Top 2% 1.9%
13
Science Translational Medicine
40 training papers
Top 1% 1.5%
14
eLife
262 training papers
Top 29% 1.5%
15
JCI Insight
63 training papers
Top 4% 1.5%
16
Emerging Infectious Diseases
84 training papers
Top 8% 1.5%
17
Science
46 training papers
Top 2% 1.5%
18
The Lancet Infectious Diseases
57 training papers
Top 3% 1.5%
19
eBioMedicine
82 training papers
Top 7% 1.2%
20
Journal of Medical Virology
95 training papers
Top 10% 1.2%
21
Cell Reports
25 training papers
Top 1% 0.9%
22
Open Forum Infectious Diseases
124 training papers
Top 14% 0.9%
23
iScience
74 training papers
Top 10% 0.9%
24
PLOS ONE
1737 training papers
Top 98% 0.9%
25
Nature Microbiology
21 training papers
Top 0.4% 0.9%
26
Vaccine
140 training papers
Top 8% 0.9%
27
Vaccines
131 training papers
Top 11% 0.9%
28
PLOS Pathogens
35 training papers
Top 2% 0.9%
29
Proceedings of the National Academy of Sciences
100 training papers
Top 21% 0.7%
30
npj Vaccines
18 training papers
Top 0.9% 0.7%